- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05369572
Connection Between Tongue Signs and Bile Reflux Analysed With Artificial Intelligence
Analysing the Link Between Tongue Signs and Bile Reflux by Artificial Intelligence
Study Overview
Status
Conditions
Detailed Description
Firstly, after the patient signs the informed consent form, the researcher will collect pictures of the patient's tongue and obtain basic information about the patient.
Second, the patients are scored on the Anxiety and Depression Scale.
Thirdly, after the patient undergoes gastroscopy, the patient's gastroscopy report is obtained.
Finally, the patient's tongue image, information and gastroscopy report are matched to construct an artificial intelligence model of tongue image and bile reflux and anxiety and depression, and the quality of the model is assessed.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Shandong
-
Jinan, Shandong, China, 250012
- Qilu hosipital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients aged 18 to 80 years who wish to undergo gastroscopy.
- Patients have given their informed consent and signed the informed consent form.
Exclusion Criteria:
- Serious heart, liver, kidney or other underlying illness, or mental illness.
- Patients taking anti-anxiety or depression medication within 3 months.
- Current H. pylori infection.
- History of surgery on the digestive or biliary tract.
- Peptic ulcer, malignant tumour of the digestive tract, etc.
- Patients taking bismuth or other staining medications.
- Pregnant or lactating women.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Bile Reflux Group
Gastroscopic reports of enrolled patients will be extracted and patients will be identified as having bile reflux according to Kellosalo J classification. Grade I: small amount of yellowish reflux emerging from the pyloric orifice and/or yellowish staining of the mucus lake, which is pale yellow in colour. Grade II: intermittent gush of reflux from the pyloric opening and/or yellowish staining of the mucus lake, which is dark yellow. Grade III: frequent gush of yellow-green reflux from the pyloric orifice and/or yellow-green mucus covering the stomach. |
|
Non-biliary reflux group
Gastroscopic reports will be extracted from patients enrolled in the group that do not meet the Kellosalo J classification as the non-biliary reflux group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sensitivity
Time Frame: 3 years
|
Sensitivity of artificial intelligence models Sensitivity = number of true positives / (number of true positives + number of false negatives) * 100%.
|
3 years
|
|
Specificity
Time Frame: 3 years
|
Specificity of Artificial Intelligence Models Specificity = number of true negatives / (number of true negatives + number of false positives)) *100% |
3 years
|
|
Positive predictive values(PPV)
Time Frame: 3 years
|
Positive predictive values from artificial intelligence models Positive predictive value = true positive / (true positive + false positive) *100%
|
3 years
|
|
Negative predictive values (NPV)
Time Frame: 3 years
|
Negative predictive values for artificial intelligence models Negative Predictive Value = True Negative / (True Negative + False Negative) *100%
|
3 years
|
|
AUC (95% CI)
Time Frame: 3 years
|
area under the receiver operating characteristic curve (AUC),
|
3 years
|
|
Accuracy
Time Frame: 3 years
|
Accuracy for artificial intelligence models Accuracy = (true positives + true negatives) / total number of subjects * 100%
|
3 years
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022SDU-QILU-G002
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.